INVO Bioscience, Inc. Stock price
Equities
INVO
US44984F4019
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.13 USD | +2.73% | +2.73% | -16.30% |
Financials (USD)
Sales 2023 * | 3.59M | Sales 2024 * | 14.84M | Capitalization | 2.82M |
---|---|---|---|---|---|
Net income 2023 * | -9M | Net income 2024 * | -4M | EV / Sales 2023 * | 0.78 x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 0.19 x |
P/E ratio 2023 * |
-0.19
x | P/E ratio 2024 * |
-3.9
x | Employees | 16 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 99.07% |
Latest transcript on INVO Bioscience, Inc.
1 day | +2.73% | ||
1 week | +2.73% | ||
Current month | -1.74% | ||
1 month | +3.65% | ||
3 months | -19.29% | ||
6 months | +32.15% | ||
Current year | -16.30% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Shum
CEO | Chief Executive Officer | 55 | 17-10-10 |
Andrea Goren
DFI | Director of Finance/CFO | 56 | 21-06-13 |
Chief Tech/Sci/R&D Officer | - | 20-02-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trent Davis
BRD | Director/Board Member | 56 | 19-12-15 |
Barbara Ryan
BRD | Director/Board Member | 64 | 20-09-13 |
Corporate Secretary | 55 | 08-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.13 | +2.73% | 14,363 |
24-03-27 | 1.1 | +8.91% | 18,562 |
24-03-26 | 1.01 | -11.40% | 16,615 |
24-03-25 | 1.14 | +0.88% | 40,099 |
24-03-22 | 1.13 | +2.73% | 8,875 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.30% | 2.82M | |
+3.26% | 197B | |
+5.79% | 116B | |
+1.48% | 71.49B | |
+11.77% | 53.47B | |
+18.31% | 48.42B | |
+6.33% | 43.64B | |
+12.38% | 28.97B | |
+9.76% | 28.47B | |
+10.35% | 27.78B |